Episode 230 | Eduardo Palma, Senior Analyst at 415 Capital |Investing in Lifesaving Innovation & Strategies for Startups' Success episode artwork

EPISODE · Sep 1, 2025 · 42 MIN

Episode 230 | Eduardo Palma, Senior Analyst at 415 Capital |Investing in Lifesaving Innovation & Strategies for Startups' Success

from Project Medtech · host Project Medtech

In this episode, Duane Mancini welcomes to the show Eduardo Palma, a senior analyst at 415 Capital, a VC firm specializing in cardiovascular medtech investments. Eduardo shares insights on his background, the emergence of Portugal as a VC hub, and the strategic advantages of their Munich base. The conversation explores 415 Capital’s origin, investment thesis, and their unique focus on clinical-stage PMA-track devices. Highlights include the critical role of clinical data, strategies for effective fundraising, and the importance of teamwork between VCs and startups. Eduardo also discusses the challenges and learning experiences of raising a second fund, offering invaluable advice for startups aiming to stand out in their pitches.Eduardo Palma LinkedIn415 Capital LinkedIn415 Capital WebsiteDuane Mancini LinkedInProject Medtech WebsiteProject Medtech LinkedIn

Episode metadata supplied by the publisher feed · Published Sep 1, 2025

Embed this episode

Ready to play

Episode 230 | Eduardo Palma, Senior Analyst at 415 Capital |Investing in Lifesaving Innovation & Strategies for Startups' Success

0:00 42:08

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Project Medtech?

This episode is 42 minutes long.

When was this Project Medtech episode published?

This episode was published on September 1, 2025.

Can I download this Project Medtech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!